UNSPSC 51372300: Controlled substance analgesic piperidines

Controlled substance analgesic drugs made from a family of hexahydropyridines.

UNSPSC 51372300 Controlled substance analgesic piperidines, a Class code, covers pharmaceutical products sourced by state and local public health agencies, though the recent opportunity record shows limited direct alignment with the code's nominal scope. Seminole County, Florida's June 2026 IFB for naloxone and drug deactivation systems—a harm-reduction and overdose-reversal procurement—represents the primary recent activity visible under this code. Naloxone and safe drug deactivation systems serve opioid overdose response and community health support roles rather than therapeutic analgesic use, signaling that the code as currently tagged may capture emergency medical countermeasures and public health supplies alongside traditional controlled-substance pharmaceutical inventories.

The issuing body is a county public health administration (Seminole County Community Health Building) rather than a state department or school district. Geographically, the recent opportunity is concentrated in Florida with a July 26, 2023 response deadline (note: the posting date of June 30, 2026 in the record appears inconsistent with the stated response deadline). The Seminole County IFB calls for 1,900 units of naloxone and 800 safe drug deactivation systems annually on a fixed-fee basis with a two-year initial term and one-year renewal option, with quarterly deliveries required and all shipping included in vendor pricing. The procurement imposes standard compliance conditions—E-Verify, drug-free workplace certification, workers' compensation and general liability insurance—and potential FEMA funding implications subject to federal environmental compliance. Beyond this single visible opportunity, the code shows no recent state-local contract postings in the source record.